NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Arbele Limited

Arbele Limited

Private
Hong KongHealthcare & Life Scienceshttps://www.arbelebio.com/

Last Round

Seed

Apr 7, 2021

Total Funding Raised

$428,000

Company Overview

Arbele Limited is a biotechnology company that develops multi-specific antibody therapeutics, antibody-drug conjugates (ADCs), and cell therapies for treating gastrointestinal cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

cancer immunotherapygastrointestinal cancerGI cancerCDH17 biomarkerclinical stage biotechantibody drug conjugateADCbispecific antibodyT-cell engageroncology drug developmentCAR-T therapypancreatic cancercell therapycompanion diagnosticsCAR-NK therapydrug co-development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arbele Limited Comps

Public and private peers based on sector, stage, and business model.

Arbele Limited comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arbele Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 7, 2021

Key People

Founding team and executive leadership

Chun Fung Chan

Chief Technology Officer

Executive Team

Tony Wong

Chief Technology Officer

Executive Team

Arbele Limited Investors

Notable investors and investment history

Arbele Limited investors
InvestorRounds
Asian Fund for Cancer ResearchSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2026

    Grew 25% QoQ, from 16 to 20 employees.

Arbele Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arbele Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arbele Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersHong Kong
Employee Range19
Year Founded2016
Last FundingApr 7, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.